Sr. Director (medical) Oral Therapies

Eli Lilly Eli Lilly · Pharma · Mexico City, Mexico

This role is for a Sr. Director (Medical) Oral Therapies at Eli Lilly, focusing on medical affairs and clinical research. The position involves strategic planning for launch and commercialization activities, supporting local clinical trials, managing adverse event reporting, reviewing protocols and publications, and interacting with regulatory and reimbursement agencies. The role requires scientific and medical expertise to support marketed products and potentially early-phase trials, ensuring all activities comply with regulations and company standards.

What you'd actually do

  1. provide expert medical support to all aspects of the local business, to ultimately enhance the customers' experience in interacting with the company.
  2. local marketed product support (participate in the development of the "patient journey" and the strategic plan for the compound)
  3. medical support for regulatory affairs and interactions with Cofepris, if necessary (medical support for New and Supplemental New Drug Submissions and participating and presenting at meetings with government regulatory agencies)
  4. medical support for pricing, reimbursement and access(PRA) (providing medical guidance on the PRA plan and interacting with government PRA agencies as needed)
  5. leading in local scientific data dissemination (leading and presenting at conferences, advisory boards, etc., and overseeing the development of the scientific content of educational programs).

Skills

Required

  • Scientific and medical training
  • Clinical expertise
  • Relevant clinical experience
  • Medical Affairs
  • Clinical Research
  • Strategic planning
  • Launch and commercialization activities
  • Local clinical trials
  • Adverse event reporting
  • Protocol review
  • Study report review
  • Publication review
  • Data dissemination
  • Labeling
  • Pricing
  • Reimbursement
  • Access
  • Grant submissions
  • Contract management
  • Regulatory agency interaction
  • Governmental agency interaction
  • External clinical customer community engagement
  • Thought leader engagement
  • Medical vision alignment
  • Scientific resource provision
  • Compliance with regulations (FDA, ICH, CPMP)
  • Good Clinical Practices (GCPs)
  • Company standards
  • Lilly policies
  • Global quality standards
  • Principles of Medical Research
  • Late-phase trial support
  • Early-phase trial support
  • Phase I/II/IIIb/IV trial collaboration
  • Non-clinical trial solution development
  • Global Development study support
  • Marketed product support
  • Patient journey development
  • New Drug Submission support
  • Supplemental New Drug Submission support
  • Payer partnership program development
  • Product value defense
  • Business-to-business support
  • Business-to-government support
  • Promotional material review

Nice to have

  • Oral Therapies expertise

What the JD emphasized

  • medical plan
  • clinical trials
  • adverse events
  • regulatory
  • publications
  • pricing
  • reimbursement
  • access
  • grant submissions
  • contracts
  • governmental agencies
  • thought leaders
  • patient safety
  • Good Clinical Practices
  • company standards
  • Lilly policies
  • global quality standards
  • Principles of Medical Research
  • medical vision
  • late-phase trials
  • early phase trials
  • phase I
  • phase II
  • phase 3b/4 studies
  • non clinical trial solutions
  • clinical plan
  • global Development studies
  • marketed product support
  • patient journey
  • strategic plan
  • New Drug Submissions
  • Supplemental New Drug Submissions
  • payer partnership programs
  • product value
  • business-to-business
  • business-to-government
  • promotional materials